Medication surveillance concerning hypersensitivity reactions to drugs: the Dutch approach Froukje Harkes-Idzinga KNMP, The Hague October / November 2016.

Slides:



Advertisements
Similar presentations
Disease State Management The Pharmacist’s Role
Advertisements

International Experience in Pharmaceutical Services for Promoting Access to Medicines: Canada, Cuba, England, Mexico International Seminar on the Challenges.
New ISO projects Joint meeting HL7, IHE and ISO Pharmacy groups Leonora Grandia, Z-Index.
Medical informatics management EMS 484, 12 Dr. Maha Saud Khalid.
Antibiotic Resistance and Medicinal Drug Policy Dr. Ken Harvey Dr. Ken Harvey School of Public Health, La Trobe University, Melbourne, Australia 1.
The basics about over-the-counter and prescription drugs. 1 Medicine 101.
Issues Related to Medication in the Schools Module 3.
Pharmacy Services.
 Definitions  Goals of automation in pharmacy  Advantages/disadvantages of automation  Application of automation to the medication use process  Clinical.
Pharmaceutical applications Patrick Bongo BSc (Hons), MSc, PGCE, MBCS.
Handbook of Informatics for Nurses and Healthcare Professionals Copyright ©2009 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights.
In Which Areas Have Clinical Pharmacists Been the Most Successful in Patient Care ? Hospital inpatient unit (wards) –Therapeutic drug monitoring –Anticoagulation.
Pharmacy Administrator: Manager / Adminstrator for Pharmacies Research Leader for: oUoUniversities oHoHealth Insurance oPoPharmaceutical Companies.
FDA Risk Management Workshop: Concept Paper: Risk Management Programs April 10, 2003 Gary C. Stein, Ph.D. Director of Federal Regulatory Affairs American.
Prescriptions Chapter 5 Start Quiz. Who can write prescriptions for drugs?
ACCESS TO MEDICINES - POLICY AND ISSUES
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Methods to Evaluate and Improve National Policy: Focus on 2011 WHO Guidelines and PPSG Global Policy Evaluation Aaron M. Gilson, MS, MSSW, PhD Research.
Using Medicines Safely (2:50) Click here to launch video Click here to download print activity.
Principles of Medication Administration and Medication Safety Chapter 7 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of.
Medication Error Reduction Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
“USAPI-PHARMACY ASSOCIATION - RESPONSE TO NCD ROADMAP” Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa 51 st 1-18 nov 2011 Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa.
Chapter 6 Dispensing Medications in the Community Pharmacy.
MEDICATION MANAGEMENT P&T COMMITTEE AND FORMULARY MANAGEMENT EMTENAN ALHARBI, Msc CLINICAL PHARMACIST.
Signal identification and development I.Ralph Edwards.
DRUG ACT 1976 SPECIFIC OBJECTIVES:
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Documentation in Practice Dept. of Clinical Pharmacy.
Medicines Authority 203,Level 3, Rue D’Argens, Gzira,GZR 1368 Tel: (+356) Fax: (+356) ov.mt Reporting.
PHARMACEUTICAL GUIDELINES: BASIC PRINCIPLES AND STATUTES.
Karen Harrowing – Senior Associate
Understanding Health Care Policy
Off-label Use.
Safety in the Pharmacy.
Antibiotics: handle with care!
Assisting the pharmacist
Wireless Access SSID: cwag2017
Information on Medicinal Products
PHARMACIST : A HEALTH CARE PROFESSIONAL
STRATEGIES TO PREVENT MEDICATION ERRORS
Drugs and Prescription Records
Drugs and Prescription Records
Risk Communication in Medicines
Froukje Harkes-Idzinga, Pharm. D
Community Hospital Pharmacy Practice January 29, 2004
San Francisco County OBOT Pilot: Pharmacy Aspects
Cooperation for Better Regulation
Using Medicines Safely (2:50)
Introduction to Clinical Pharmacy
US Prescribers and Biosimilars Naming
Inaugural Expert Council Meeting at E.M.A. London June 25, 2015
Learning Objectives Enumerate typical duties of pharmacy technicians with regard to dispensing of over-the-counter and prescription drugs. Explain the.
13 September 2018 PHPID and its enabler role for identification of medicines for e-prescription Towards a trans-atlantic solution to univocally identify.
INTEGRATED ELECTRONIC HEALTH RECORD SYSTEM
CHAPTER 4 Information Management in Pharmacy.
Legal Aspects Affecting the Administration of Medications
68.3 million errors (28% of total) cause moderate or serious harm
Health Technology Assessment
Chapter 5 Prescriptions.
Pharmacy practice experience I
Issues on Dispensing Dr Percy Mahlathi.
Medicines Safety Programme
Using Medicines Safely (2:50)
Innovations of e-prescriptions in Albania
Using Medications Wisely Consumer Education Update
Ch 18: Pharmacy.
Health Care Information Systems
Compounded Drugs and Lack of Premarket FDA-Approval
Hospital pharmacy.
Let’s talk medicines safety
Presentation transcript:

Medication surveillance concerning hypersensitivity reactions to drugs: the Dutch approach Froukje Harkes-Idzinga KNMP, The Hague October / November 2016

Program: G-Standaard decision support concerning hypersensitivity reactions to drugs guideline on registration and exchange of characteristics of hypersensitivity reactions to drugs

Use of the G-Standaard Manufacturer Physician Pharmacy Patient visit Physician goods Wholesaler order Health insurer invoice Pharmacy prescription medication Manufacturer

Content of the G-Standaard (in general) The G-Standaard contains: all (licensed) medicines available in the Netherlands, including OTC homoeopathic products medical devices and provides information on: logistics, legal status, reimbursement (for all products) pharmaceutical characteristics (for medicines) decision support (for medicines) The G-Standaard contains: all registered medicines available in the Netherlands, including OTC, and some other OTC health products, such as St. John’s wort with it’s danger of drug-interactions. It also contains homoeopathic as well as anthroposophic products and medical devices, such as catheters and bandages. For all registered medicines, the database provides information on pharmaceutical characteristics, such as active ingredients pharmaceutical form, like tablets or solutions, and route of administration, Also for registered medicines, it contains medication surveillance data for decision support by the healthcare professional. This information is also being provided for the other OTC health products, but not for the homoepathic and anthroposophic products. It also contains useful information on logistics, legal status and reimbursement. For example concerning logistics how many units one package contains, and concerning legal status whether a product is prescription only, available only in pharmacies, or also at the chemists’ or, as we call it in the Netherlands, at the gas station.

File 750 File 711 File 715 File 050 File 031 File 004

examples niveau example SNK (basic substance) Morphine GNK (substance) Morphine HCl-3-H2O GPK (GeneriekeProductKode, basic product) Morphine injvlst 10mg/ml [contains morphine HCl-3-H2O 10 mg] PRK (PRescriptieKode, prescription product) Morphine injvlst 10mg/ml amp 1ml HPK (HandelsProductKode, trade product) Morphine HCl PCH injvlst 10mg/ml ampul 1ml ZI-number (Consumer item) Morphine HCl PCH injvlst 10mg/ml ampul 1ml (10 st )

From database to clinical decision support Clinical decision support for: General Practitioner Medical Specialist (hospital) pharmacist Information from databases incorporated in: Prescribing system Pharmacy System Databases: G-Standaard PharmaBase

Hypersensitivity (e.g. allergy) Features: Alert groups with possible cross-reactivity no practical guideline Information based on: SPC expert opinion

Guideline National Working Group with delegates from professional organisations of both physicians and pharmacists and Nictiz guideline on registration and exchange of characteristics of hypersensitivity reactions to drugs (concept) characteristics in guideline: drug (substance or product) or group with possible cross-reactivity symptom(s) of worst hypersensitivity reaction seriousness of hypersensitivity reaction source policy (can de drug be prescribed again in the future or not? So, medication surveillance, or decision support, plays an important role in the prevention of medication errors. I have told you about the different types of medication surveillance data that are available in the G-Standaard. As the G-Standaard is incorporated in computerized systems for healthcare professionals, these checks can be performed during prescription and before dispensing. Most types of alerts are accompanied by practical guidelines on how to deal with the alert. Also, evidence is made transparant as it is provided in a data sheet. However important, the fact remains that medication surveillance introduces alerts healthcare professionals have to deal with. This means it takes time and effort in day-to-day clinical practice. It is important to remain aware of this, to find a balance between getting all important alerts, but also not to create alert fatigue. (GOED OMSCHREVEN?) Now I have told you about the advantages and challenge of medication surveillance, or decision support, using the G-Standaard, I would like to turn you over to my collegue, Frits Elferink, who will tell you about the structural characteristics of this database.

Global Substance Registration System (G-SRS) is being designed at the moment takes into account ISO IDMP Standards might be of use to our project project leader: Herman Diederik (Medicines Evaluation Board, the Netherlands)

more information: f.harkes-idzinga@knmp.nl Questions? more information: f.harkes-idzinga@knmp.nl